Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Russell Skibsted

CFO at Processa Pharmaceuticals, Inc. (PCSA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$16K
Total bought / sold$42K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Jul 1SEC PCSAProcessa Pharmaceuticals, Inc. Buy 3,27716,689 held (+24%) $1.93 $6K -21.2%
Jun 16SEC PCSAProcessa Pharmaceuticals, Inc. Buy 2,65413,412 held (+25%) $2.22 $6K -31.5%
Jun 1SEC PCSAProcessa Pharmaceuticals, Inc. Buy 2,29210,758 held (+27%) $2.57 $6K -40.9%
May 19SEC PCSAProcessa Pharmaceuticals, Inc. Buy 1,9848,466 held (+31%) $2.97 $6K -48.8%
May 1SEC PCSAProcessa Pharmaceuticals, Inc. Buy 2,1906,498 held (+51%) $2.69 $6K -43.5%
Apr 17SEC PCSAProcessa Pharmaceuticals, Inc. Buy 1,9844,308 held (+85%) $2.97 $6K -48.8%
Apr 1SEC PCSAProcessa Pharmaceuticals, Inc. Buy 2,324new position $2.54 $6K -40.2%
  • Buy

    CFO Russell Skibsted bought $6K of PCSA at $1.93 — largest purchase by this insider in our records; raises the stake by 24%.

  • Buy

    CFO Russell Skibsted bought $6K of PCSA at $2.22 — raises the stake by 25%.

  • Buy

    CFO Russell Skibsted bought $6K of PCSA at $2.57 — raises the stake by 27%.

  • Buy

    CFO Russell Skibsted bought $6K of PCSA at $2.97 — raises the stake by 31%.

  • Buy

    CFO Russell Skibsted bought $6K of PCSA at $2.69 — raises the stake by 51%.

  • Buy

    CFO Russell Skibsted bought $6K of PCSA at $2.97 — raises the stake by 85%.